Preparation for the prevention and/or treatment of vascular disorders
First Claim
Patent Images
1. A method for treating a person suffering from or at risk of degeneration of cerebral function, cognitive degeneration and/or dementia syndromes, comprising administering to a person in need thereof a preparation, comprising:
- a) at least 120 mg long chain polyunsaturated fatty acid fraction comprising docosahexaenoic acid (DHA);
b) at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine; and
c) at least one factor in methionine metabolism selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium, zinc, and equivalents thereof.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions:
- fraction a) consisting of long chain polyunsaturated fatty acids;
- fraction b) consisting of phospholipids, which fraction contains at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine.
- fraction c) consisting of compounds which are a factor in methionine metabolism, which fraction contains at least one member selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium and zinc.
-
Citations
30 Claims
-
1. A method for treating a person suffering from or at risk of degeneration of cerebral function, cognitive degeneration and/or dementia syndromes, comprising administering to a person in need thereof a preparation, comprising:
-
a) at least 120 mg long chain polyunsaturated fatty acid fraction comprising docosahexaenoic acid (DHA); b) at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine; and c) at least one factor in methionine metabolism selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium, zinc, and equivalents thereof. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)
-
-
30. A method for treatment of vascular disorders or disorders associated therewith, comprising administering to a person in need thereof a preparation, comprising:
-
a) at least 120 mg long chain polyunsaturated fatty acid fraction comprising docosahexaenoic acid (DHA); b) at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine; and c) at least one factor in methionine metabolism selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium, zinc, and equivalents thereof.
-
Specification